Loading
Latest filing published 22 May 2020 for Tetra Bio-Pharma Inc., €3,142.
William Cheliak is a declared insider of Tetra Bio-Pharma Inc., with filings sourced from SEDI. Between 9 May 2019 and 22 May 2020, the trades on record add up to 4 filings.
No open-market sale appears; the market trades are 2 purchases worth €4,405. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2020 alone, the filings show 1 purchase and no sales.
The latest filing, published on 22 May 2020, reports an open-market purchase of €3,142 in Tetra Bio-Pharma Inc. Between a trade and the moment it shows up on SEDI, the median delay is 1 day. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations